Beta-Lactamases in a Tertiary Care Hospital: "Biological Quake" Knocking at the Door
Keywords:
Antibiotic resistance, ESBL, Hospital-admitted patients, MBLAbstract
Background: Antimicrobial resistance due to the production of extended-spectrum β-lactamases (ESBLs), AmpC β-lactamases, and metallo-β-lactamases (MBLs) have emerged as a major health catastrophe limiting antibiotic treatment options. Therefore, this study was conducted to assess the current level of ESBLs, AmpC β-lactamases, and MBLs- producing bacteria and their antibiotic susceptibility profile in a Nepalese hospital.
Methods: This was a cross-sectional study carried out among the inpatients of Medicare National Hospital, Kathmandu from April to September 2015. During the study period, a total of 589 specimens (urine, sputum, blood, pus, body fluids, throat swab, central venous catheter - CVC tip) collected aseptically from the admitted patients were selected in the study. The collected specimens were processed, and the isolated organisms were identified following the standard microbiological methods. ESBL was detected by standard combination disc method and double-disc synergy test.
Results: Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, Enterococcus faecalis, and Candida albicans were the common microbial agents isolated from hospital-admitted patients. Among total 84 Gram-negative bacteria tested for ESBL-production, 23 (27.4%) isolates were ESBL-producers. ESBL production was seen in 32.3% of Escherichia coli and 28.6% of Klebsiella pneumoniae isolates. Similarly, MBL production was identified in 28.6% of Pseudomonas aeruginosa, and 6.5% of Escherichia coli. Likewise, 3.2% of Escherichia coli were AmpC β-lactamase-producers. The ESBL-producing bacteria showed less susceptibility to different antibiotics as compared to non-ESBL-producers. Consistent results were found with different methods like combination disk method, MASTDISKSTM ID AmpC and ESBL disk, Ezy MICTM Strip (MIX+/MIX) method, and triple ESBL detection Ezy MICTM strips employed for the detection of ESBL and AmpC.
Conclusions: ESBL was commonly seen in Escherichia coli while MBL in Pseudomonas aeruginosa. Routine monitoring of these kinds of resistance phenotypes following appropriate methods is essential for the proper treatment of patients.
Keywords: Antibiotic resistance, Beta-lactamases, ESBL, Hospital-admitted patients, MBL
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 Shyam Mishra, Gyanendra Sapkota, Santosh Yadav, Samaj Adhikari, Prof. Dr
This work is licensed under a Creative Commons Attribution 4.0 International License.
The author(s) retain the copyright and the full publishing right without restriction under the Creative Commons Attribution 4.0 International License (CC BY 4.0) which allows readers to share (copy and redistribute the material in any medium or format) and adapt (remix, transform, and build upon the material) for any purpose, even commercially, provided the work is properly attributed. (https://creativecommons.org/licenses/by/4.0/).
Author(s) grant the non-exclusive publishing right to the Journal of Karnali Academy of Health Sciences (JKAHS). The publishing rights include the rights to publish, reproduce, distribute, include in indexes or search databases or other media in print or online. The JKAHS may require revisions to the manuscript before acceptance for publication or may choose not to publish it based on the judgement of the editors. Further, JKAHS might retract, withdraw, or publish a correction or other notice after publication, if such publication would be inconsistent with the good publication practices and associated guidelines set forth by the COPE (Committee on Publication Ethics) (https://publicationethics.org/core-practices).
More information about the Creative Commons Attribution 4.0 International License can be found in the webpage of Creative Commons (CC) by following the link provided below: https://creativecommons.org/licenses/by/4.0/
